Chronic obstructive pulmonary disease: The need for differentiation and individualization of short and long-term treatment of a complex disease
More details
Hide details
2nd Respiratory Medicine Department, University of Athens, “Attikon” General Hospital, Athens Medical School
7th Respiratory Medicine Department, “Sotiria” Hospital, Athens, Greece
Corresponding author
Spyros Α. Papiris   

2nd Respiratory Medicine Department, University of Athens, “Attikon” General Hospital, Athens Medical School, Athens Greece 1 Rimini street, 12461 Chaidari Athens, Greece
Pneumon 2015;28(4):318–320
Republication after written permission from the Journal “THE DOCTOR”.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. Available from: http://www.goldcopd.org/. Last accessed 17 August 2015.
Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128-38.
D’Urzo A, Donohue JF, Kardos P, et al. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opin Pharmacother 2015; 16:1845-60.
Martinez-Garcia MÁ, Soler-Cataluña JJ, Donat SY, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011; 140:1130-7.
O’Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterization of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55:635-42.
Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:400-7.
McGarvey L, Lee AJ, Roberts J, et al. Characterization of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med 2015; 109:228-37.
Vogelmeier C, Buhl R, Criee CP, et al. Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort (Abstract). Eur Respir J 2014; 44(Suppl 58):P930.
Izquierdo Alonso JL, Rodríguez Glez-Moro JM. The excessive use of inhaled corticosteroids in chronic obstructive pulmonary disease. Arch Bronconeumol 2012; 48:207-12.
Magnussen H, Disse B, Rodriguez-Roisin R, et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med 2014; 371:1285-94.